SPONSOR
Gates Medical Research Institute
Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 2
Gates Medical Research Institute is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Healthy Adult Participants, Drug Susceptible Pulmonary Tuberculosis.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Gates Medical Research Institute
How many clinical trials has Gates Medical Research Institute sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Gates Medical Research Institute, of which 2 are actively recruiting participants. These trials cover conditions including Healthy Adult Participants, Drug Susceptible Pulmonary Tuberculosis. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Gates Medical Research Institute research focus on?
Gates Medical Research Institute clinical trials span Healthy Adult Participants, Drug Susceptible Pulmonary Tuberculosis. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Gates Medical Research Institute clinical trial?
To participate in a Gates Medical Research Institute trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Gates Medical Research Institute trials with current recruitment status updated daily.
Clinical Trials by Gates Medical Research Institute
NCT07883226 Phase 1
Recruiting
A Phase 1 Multiple Dose Trial in Healthy Adult Participants to Evaluate the Safety, Tolerability, Drug-Drug Interactions, and Pharmacokinetics of TBD11
Healthy Adult Participants
NCT07525427 Phase 2
Recruiting
Bactericidal Activity of TBD09 in Combination With Other Drugs in Pulmonary Tuberculosis
Drug Susceptible Pulmonary Tuberculosis
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology